Xenon Pharmaceuticals (XENE)

• Market cap: $3.46B
• 1 day: 1.59%
• 5 days: 0.4%
• 1 month: 3.01%
• 3 months: 11.63%
• 6 months: 43.19%
• Year to date: 11.58%
• 1 year: 14.34%
• 5 years: 191.42%
• 10 years: 457.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Employees: 327